All stock lists
Revolution Medicines, Inc. (NASDAQ:RVMD)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
183.92-3.07 (-1.64%)
Insider Score
––Not scored
RVMD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RVMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 4.54 M | 4.70 M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -4.54 M | -4.70 M | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 110.21 M | 101.25 M | 64.32 M | 52.76 M | 40.58 M | 35.01 M |
| R&D Expense | 394.92 M | 343.97 M | 292.61 M | 262.51 M | 224.13 M | 205.75 M |
| Operating Expenses | 505.13 M | 440.69 M | 356.92 M | 315.27 M | 264.71 M | 240.76 M |
| Operating Income | -505.13 M | -445.22 M | -361.63 M | -315.27 M | -264.71 M | -240.76 M |
| Pretax Income | -644.37 M | -453.82 M | -364.89 M | -305.21 M | -247.79 M | -213.42 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -644.37 M | -453.82 M | -364.89 M | -305.21 M | -247.79 M | -213.42 M |
| EPS (Basic) | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 |
| EPS (Diluted) | -3.06 | -2.29 | -1.90 | -1.61 | -1.31 | -1.13 |
| Shares Outstanding | 210.89 M | 198.10 M | 190.13 M | 189.23 M | 188.15 M | 188.15 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.